Acadia posts Q4 revenue of USD 821.5 million up 6.1%

Reuters02-25 20:03
Acadia posts Q4 revenue of USD 821.5 million up 6.1%

Acadia reported Q4 2025 revenue of USD 821.5 million (+6.1%), with same-facility revenue up 4.4% on patient days up 3.1% and revenue per patient day up 1.3%. Q4 net loss attributable to shareholders was USD 1.178 billion, or (USD 13.02) per diluted share, driven by a non-cash goodwill impairment charge of USD 996.2 million; adjusted net income attributable to shareholders was USD 6.1 million (USD 0.07 per diluted share) and adjusted EBITDA was USD 99.8 million. In Q4, Acadia recorded a USD 52.7 million adjustment to professional and general liability reserves and a USD 147.0 million legal settlements expense related primarily to the 2019 securities litigation settlement, net of expected insurance recoveries. For FY 2025, revenue was USD 3.31 billion (+5.0%), adjusted EBITDA was USD 608.9 million, and net loss attributable to shareholders was (USD 12.16) per diluted share; adjusted net income attributable to shareholders was USD 182.7 million (USD 2.00 per diluted share). Development highlights included 1,089 licensed beds added in FY 2025 (including 181 in Q4) and the opening of the 144-bed ECU Health Behavioral Health Hospital joint venture in Greenville, North Carolina; Acadia also added one new comprehensive treatment center in Q4, ending 2025 with 178 CTCs across 33 states. CEO Debbie Osteen said Q4 reflected improved volume growth and outlined priorities focused on leadership, operational discipline and execution improvements. Acadia guided for FY 2026 revenue of USD 3.37 billion to USD 3.45 billion, adjusted EBITDA of USD 575 million to USD 610 million, and adjusted diluted EPS of USD 1.30 to USD 1.55.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acadia Healthcare Company Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260224788871) on February 25, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment